SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

Emerg Infect Dis. 2021;27(10):2720-2723. doi: 10.3201/eid2710.211461. Epub 2021 Jul 23.

Abstract

We report persistent severe acute respiratory syndrome coronavirus 2 infection in a patient with HIV/AIDS; the virus developed spike N terminal domain and receptor binding domain neutralization resistance mutations. Our findings suggest that immunocompromised patients can harbor emerging variants of severe acute respiratory syndrome coronavirus 2.

Keywords: 2019 novel coronavirus disease; COVID-19; California; HIV/AIDS; SARS-CoV-2; United States; antimicrobial resistance; coronavirus disease; coronaviruses; immunocompromised; respiratory infections; severe acute respiratory syndrome coronavirus 2; viral evolution; viruses; zoonoses.

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • COVID-19*
  • Humans
  • Mutation
  • Protein Binding
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics

Substances

  • Spike Glycoprotein, Coronavirus